104 related articles for article (PubMed ID: 2568263)
1. [3H]SCH 23390 labels a novel 5-hydroxytryptamine binding site in human blood platelet membranes.
De Keyser J; Walraevens H; Convents A; Ebinger G; Vauquelin G
Eur J Pharmacol; 1989 Mar; 162(3):437-45. PubMed ID: 2568263
[TBL] [Abstract][Full Text] [Related]
2. What intracranial tissues in humans contain sumatriptan-sensitive serotonin 5-HT1-type receptors?
De Keyser J; Vauquelin G; De Backer JP; De Vos H; Wilczak N
Neurosci Lett; 1993 Dec; 164(1-2):63-6. PubMed ID: 8152617
[TBL] [Abstract][Full Text] [Related]
3. [3H]SCH 23390 labels dopamine D-1 receptor sites in the rat kidney.
Zdilar D; Lacković Z
Eur J Pharmacol; 1989 May; 164(1):159-62. PubMed ID: 2568936
[TBL] [Abstract][Full Text] [Related]
4. Identification of multiple binding sites for [3H]5-hydroxytryptamine in the rat CNS.
Blurton PA; Wood MD
J Neurochem; 1986 May; 46(5):1392-8. PubMed ID: 3958711
[TBL] [Abstract][Full Text] [Related]
5. Two distinct serotonin receptors: regional variations in receptor binding in mammalian brain.
Peroutka SJ; Snyder SH
Brain Res; 1981 Mar; 208(2):339-47. PubMed ID: 7214150
[TBL] [Abstract][Full Text] [Related]
6. The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptors.
Bischoff S; Heinrich M; Sonntag JM; Krauss J
Eur J Pharmacol; 1986 Oct; 129(3):367-70. PubMed ID: 3536532
[TBL] [Abstract][Full Text] [Related]
7. 5HT-receptor antagonist properties of SCH 23390 in vascular smooth muscle and brain.
Hicks PE; Schoemaker H; Langer SZ
Eur J Pharmacol; 1984 Oct; 105(3-4):339-42. PubMed ID: 6150862
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of the binding of [3H]-GR32191 to the thromboxane (TP-) receptor of human platelets.
Armstrong RA; Humphrey PP; Lumley P
Br J Pharmacol; 1993 Oct; 110(2):539-47. PubMed ID: 8242228
[TBL] [Abstract][Full Text] [Related]
9. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
Hoyer D; Engel G; Kalkman HO
Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
[TBL] [Abstract][Full Text] [Related]
10. Interaction of the D1 receptor antagonist SCH 23390 with the central 5-HT system: radioligand binding studies, measurements of biochemical parameters and effects on L-5-HTP syndrome.
Bischoff S; Heinrich M; Krauss J; Sills MA; Williams M; Vassout A
J Recept Res; 1988; 8(1-4):107-20. PubMed ID: 3290470
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of alpha 2-adrenoceptors in rat cortex but not human platelets can be defined by 8-OH-DPAT, RU 24969 and methysergide.
Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
Br J Pharmacol; 1990 Mar; 99(3):481-6. PubMed ID: 1970497
[TBL] [Abstract][Full Text] [Related]
12. 5-HT1 and 5-HT2 binding profiles of the serotonergic agents alpha-methylserotonin and 2-methylserotonin.
Ismaiel AM; Titeler M; Miller KJ; Smith TS; Glennon RA
J Med Chem; 1990 Feb; 33(2):755-8. PubMed ID: 2299641
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of the interaction of sertraline with the human platelet plasma membrane 5-hydroxytryptamine carrier.
Phillips OM; Wood KM; Williams DC
Eur J Pharmacol; 1988 Feb; 146(2-3):299-306. PubMed ID: 3371401
[TBL] [Abstract][Full Text] [Related]
14. Mianserin-induced up-regulation of serotonin receptors on normal human platelets in vivo.
Whiteford HA; Jarvis MR; Stedman TJ; Pond S; Csernansky JG
Life Sci; 1993; 53(4):371-6. PubMed ID: 8326822
[TBL] [Abstract][Full Text] [Related]
15. Binding of [3H]dihydrotetrabenazine and [125I]azidoiodoketanserin photoaffinity labeling of the monoamine transporter of platelet 5-HT organelles.
Cesura AM; Bertocci B; Da Prada M
Eur J Pharmacol; 1990 Sep; 186(1):95-104. PubMed ID: 2149340
[TBL] [Abstract][Full Text] [Related]
16. Biochemical profile of risperidone, a new antipsychotic.
Leysen JE; Gommeren W; Eens A; de Chaffoy de Courcelles D; Stoof JC; Janssen PA
J Pharmacol Exp Ther; 1988 Nov; 247(2):661-70. PubMed ID: 2460616
[TBL] [Abstract][Full Text] [Related]
17. Activation of the 5-HT1C receptor expressed in Xenopus oocytes by the benzazepines SCH 23390 and SKF 38393.
Briggs CA; Pollock NJ; Frail DE; Paxson CL; Rakowski RF; Kang CH; Kebabian JW
Br J Pharmacol; 1991 Dec; 104(4):1038-44. PubMed ID: 1687364
[TBL] [Abstract][Full Text] [Related]
18. Binding of [3H]SCH 23390 to dopamine D-1 receptors in rat retina in vitro.
Gredal O; Parkinson D; Nielsen M
Eur J Pharmacol; 1987 Jun; 137(2-3):241-5. PubMed ID: 2886353
[TBL] [Abstract][Full Text] [Related]
19. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
Makman MH; Dvorkin B
Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
[TBL] [Abstract][Full Text] [Related]
20. [125I]SCH 23982, a 'selective' D-1 receptor antagonist, labels with high affinity 5-HT1C sites in pig choroid plexus.
Hoyer D; Karpf A
Eur J Pharmacol; 1988 May; 150(1-2):181-4. PubMed ID: 3402537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]